{
    "nctId": "NCT06274034",
    "briefTitle": "MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors",
    "officialTitle": "Pilot Study of a Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Frequency of use of meditation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age between 18-80\n* Breast cancer first diagnosed with stage 1-4 breast cancer in the past 10 years\n* Patients report experiencing anxiety and insomnia both rated \\> 3 on a 0-10 scale (with 0 indicating none) at the time of enrollment\n* Patients on anti-anxiety/anti-depressant medication must be on stable dose for 1 month prior to study enrollment and must stay on that same dose throughout the trial\n* Has smart phone or tablet\n* Patient willing to use Google-based anonymous email account to sign up for MUSE\n* Be willing to provide informed consent and complete all aspects of the study\n* Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-S (trademark) system, as determined by the clinical investigators\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding individuals\n* Individuals who have used a regular mindfulness practice or received integrative medicine therapy, including acupuncture/acupressure, mindfulness or stress-reduction programs, massage, and/or energy therapies within the past 60 days\n* Currently taking medication for insomnia\n* An exclusionary unstable medical or mental health condition as determined by the patient's oncologist",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}